Two Recent Updates for our award-winning ICE Vaccine Evaluation & Forecasting System
In April, ICE expanded support for the updated dosing schedule of Bexsero (MenB‑4C), adding the new Penmenvy (CVX 328) vaccine and refines group-level recommendations for Seasonal COVID‑19 vaccines. In June ICE updated vaccine logic and forecasting for Hepatitis A, Hib, MMR, Orthopoxvirus, Pneumococcal (adult & childhood), Polio, and RSV.
|